Fig. 4From: Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosisAEBP1 silencing sensitizes oral cancer cells to SSZ treatment in vitro. A Cell viability after SSZ treatment in CAL27 cells and CAR cells. **P < 0.01 versus the CAL27 cells. B, C Cellular ROS level and lipid ROS level were detected by corresponding detection kit. **P < 0.01 versus sh-NCBack to article page